The case of pyridoxine dependent epilepsy misdiagnosed as non-ketotic hyperglycinemia

Pyridoxine-dependent epilepsy (PDE) is a rare but an important condition,since early diagnosis and treatment result in normal or near normalpsychomotor development. It is caused by mutations in the Antiquitin(ALDH7A1) gene. Different clinical findings may appear in the deficiency ofpyridoxine, which is the cofactor of many enzymes. A wide variety of clinicaland laboratory findings can cause confusion during diagnosis. We present amale with neonatal convulsions; structural brain anomaly, hyperglycinemia inCSF/plasma, with ALDH7A1 Compound heterozygote mutation.

___

1. Stockler S, Plecko B, Gospe SM Jr, et al. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. Mol Genet Metab 2011; 104: 48-60.

2. Bass NE, Wyllie E, Cohen B, Joseph SA. Pyridoxinedependent epilepsy: the need for repeated pyridoxine trials and the risk of severe electrocerebral suppression with intravenous pyridoxine infusion. J Child Neurol 1996; 11: 422-424.

3. Grillo E, da Silva RJ, Barbato JH Jr. Pyridoxinedependent seizures responding to extremely lowdose pyridoxine. Dev Med Child Neurol 2001; 43: 413-415.

4. Plecko B, Stöckler S. Vitamin B6 dependent seizures. Can J Neurol Sci 2009; 36(Suppl 2): S73-S77.

5. Aliefendioğlu D, Aslan AT, Coskun T, Dursun A, Cakmak FN, Kesimer M. Transient nonketotic hyperglycinemia: two case reports and literature review. Pediatr Neurol 2003; 28: 151-155.

6. Tada K, Kure S, Takayanagi M, Kume A, Nrisawa K. Non-ketotic hyperglycinemia: A life-threatening disorder in the neonate. Early Hum Dev 1992; 29: 75-81.

7. Maeda T, Inutsuka M, Goto K, Izumi T. Transient nonketotic hyperglycinemia in an asphyxiated patient with pyridoxine-dependent seizures. Pediatr Neurol 2000; 22: 225-227.

8. Mills PB, Footitt EJ, Mills KA, et al. Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiencey). Brain 2010; 133(Pt 7): 2148-2159.

9. Van Karnebeek CD, Tiebout SA, Niermeijer J, et al. Pyridoxine-dependent epilepsy: an expanding clinical spectrum. Pediatr Neurol 2016; 59: 6-12.

10. Stöckler-Ipsiroglu S, Van Karnebeek CDM. Pyridoxine and pyridoxal-phosphate dependent epilepsies. In: Hoffmann GF, Blau N, (eds). Congential Neurotransmitter Disorders. Nova Science Publishers; 2014: 149-166.

11. Mercimek-Mahmutoglu S, Horvath GA, CoulterMackie M, et al. Profound neonatal hypoglycemia and lactic acidosis caused by pyridoxine-dependent epilepsy. Pediatrics 2012; 129: e1368-e1372.

12. Pacifici GM. Clinical pharmacology of phenobarbital in neonates: effects, metabolism and pharmacokinetics. Curr Pediatr Rev 2016; 12: 48-54.

13. Aburawi SM, Ahmed SS, Elhwuegi AS, Saad SF, Attia AS. Brain glycine levels in triazolam-treated albino rats. J Neural Transm (Vienna) 2001; 108: 527-539.

14. Tekgul H, Serdaroğlu G, Karapinar B, et al. Vigabatrin caused rapidly progressive deterioration in two cases with early myoclonic encephalopathy associated with nonketotic hyperglycinemia. J Child Neurol 2006; 21: 82-84.

15. Baxter P, Griffiths P, Kelly T, Gardner-Medwin D. Pyridoxine-dependent seizures: demographic, clinical, MRI and psychometric features, and effect of dose on intelligence quotient. Dev Med Child Neurol 1996; 38: 998-1006.

16. Van Karnebeek CD, Hartmann H, Jaggumantri S, et al. Lysine restricted diet for pyridoxine-dependent epilepsy: first evidence and future trials. Mol Genet Metab 2012; 107: 335-344.
Turkish Journal of Pediatrics-Cover
  • ISSN: 0041-4301
  • Yayın Aralığı: Yılda 6 Sayı
  • Başlangıç: 1958
  • Yayıncı: Hacettepe Üniversitesi Çocuk Sağlığı Enstitüsü Müdürlüğü
Sayıdaki Diğer Makaleler

Could you say that was an atrial flutter or not?

Serkan ÖZSOYLU, Başak Nur AKYILDIZ, Adem DURSUN, Özge PAMUKÇU

Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of six cases

Ahu KARA, İlker DEVRİM, İlknur ÇAĞLAR, Nuri BAYRAM, Selcen KUNDAK, Hurşit APA, Emir Volkan ALTAN

Factors affecting mortality in children with dilated cardiomyopathy

Muhammed Nurullah SABAZ, Alper AKIN, Meki BİLİCİ, Fikri DEMİR, Mehmet TÜRE, Hasan BALIK

Unusual and early onset IPEX syndrome: a case report

Dilek DOĞRUEL, Fatih GÜRBÜZ, İhsan TURAN, Derya Ufuk ALTINTAŞ, Mustafa YILMAZ, Bilgin YÜKSEL

Two years of newborn screening for cystic fibrosis in Turkey: Çukurova experience

Ayşe Şenay ŞAŞİHÜSEYİNOĞLU, Derya Ufuk ALTINTAŞ, Atıl BİŞGİN, Dilek DOĞRUEL, Mustafa YILMAZ, Mahir SERBES

Optic neuropathies in childhood: a review of etiology and treatment

Ceren GÜNBEY, Bahadır KONUŞKAN

Complete atrioventricular block associated with clozapine intoxication: case report

Mehmet TÜRE, Meki BİLİCİ, Alper AKIN, Fikri DEMİR, Hasan BALIK, Savaş Mert DARAKÇI

Eleven-year surveillance of acute flaccid paralysis in southwestern Iran

Ali Akbar MOMEN, Abdolhussein SHAKURNİA, Mehdi MOMEN

Netherton syndrome previously misdiagnosed as hyper IgE syndrome caused by a probable mutation in SPINK5 C

Kemal ÖZYURT, Mustafa ATASOY, Ragıp ERTAŞ, Yılmaz ULAŞ, Muhammed Reşat AKKUŞ, Aslıhan KİRAZ, Hans Christian HENNİES

An adolescent case of extensive Behçet’s disease successfully treated with Infliximab

Emel ISIYEL, Sevcan BAKKALOĞLU, Deniz OĞUZ, İdil YENİCESU, Öznur BOYUNAĞA, Yeşim ÖZDEMİR, Çağrı DAMAR, Yaşar KANDUR, Meltem AKÇABOY, Ayşe Tana ASLAN, Tuğba ŞİŞMANLAR, Enver HASANOĞLU, Necla BUYAN